跳至主要内容
临床试验/NCT05145959
NCT05145959Unknown不适用

Meibomian Gland Probing in the Sub-Acute Phase of Patients With Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis

Massachusetts Eye and Ear Infirmary2 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2021年12月1日最近更新:
适应症

试验速览

阶段
不适用
入组人数
30
试验地点
2
主要终点
Meibomian gland imaging (Meibography) - Qualitative description

研究概览

简要总结

The investigators' aim is to study the effects of mechanical expression of meibomian glands on eyelid disease, ocular surface health in the subacute phase of SJS/TEN.

The primary outcome is to use meibomian gland imaging to assess the health and caliber of the meibomian glands of both lower eyelids, between the treated and non-treated eyes before and after the intervention. Monitoring of outcomes will be measured by comparing the results of meibography at the initial visit and at the 6-month follow-up.

The secondary outcome assessed will be patient symptoms. The Ocular Surface Disease Index survey will be administered before each treatment and patients will be asked to differentiate their symptoms between the two eyes, both before and after the intervention.

The investigators hypothesize that mechanical expression of meibomian glands within the first 6 months of SJS/TEN onset will significantly improve ocular surface disease and symptoms in those patients.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients with SJS/TEN presenting to the Massachusetts Eye and Ear Infirmary (MEEI) ophthalmology clinic or who were seen by the ophthalmology team acutely at the Massachusetts General Hospital (MGH).
  • Patients must be in the Sub-acute phase of ocular SJS (within 6 months)
  • Patients must have evidence of Meibomitis
  • Patients must be adults (18 years of age or older)

排除标准

  • Patients with unconfirmed diagnosis of SJS vs. Erythema multiforme (or other condition).
  • Patients beyond the sub-acute phase of SJS
  • Patients without evidence of Meibomitis (See above criteria)
  • Patients under the age of 18

结局指标

主要结局

Meibomian gland imaging (Meibography) - Qualitative description

时间窗: 6 months

To assess the appearance of the meibomian glands of both lower eyelids, before and after the intervention.

次要结局

  • Ocular Surface Disease Index survey(6 months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Hajirah N. Saeed, M.D.

Principal Investigator

Massachusetts Eye and Ear Infirmary

研究点 (2)

Loading locations...

相似试验